Neuropathic mechanisms in the pathophysiology of burns pruritus: Redefining directions for therapy and research

Journal of Burn Care and Research

Volumn 34, Issue 1, 2013, Pages 82-93

  Goutos, Ioannis ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CALCITONIN GENE RELATED PEPTIDE; CETIRIZINE; CHLORPHENIRAMINE; COLLAGEN; CYPROHEPTADINE; DIPHENHYDRAMINE; GABAPENTIN; HISTAMINE; HYDROXYZINE; NEUROPEPTIDE; ONDANSETRON; PROTEIN GENE PRODUCT 9.5; SUBSTANCE P; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIDROMIC STIMULATION; ARTICLE; BURN; COLLAGEN SYNTHESIS; DISEASE SEVERITY; DRUG EFFICACY; EPITHELIZATION; FIBROBLAST; HISTAMINE RELEASE; HUMAN; HYPERTROPHIC SCAR; INFLAMMATION; MACROPHAGE MIGRATION; MAST CELL; MEDIATOR RELEASE; MYOFIBROBLAST; NEUROPATHIC PAIN; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSORY DYSFUNCTION; SPINOTHALAMIC TRACT; THALAMUS; TRANSCUTANEOUS NERVE STIMULATION; VASODILATATION; WOUND CONTRACTION; WOUND HEALING;

AMINES; ANTIPRURITICS; BURNS; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HISTAMINE ANTAGONISTS; HUMANS; NEURAL PATHWAYS; NEURALGIA; NEUROPEPTIDES; ONDANSETRON; PRURITUS; SENSORY THRESHOLDS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; WOUND HEALING;

EID: 84873100035     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3182644c44     Document Type: Article

References (68)

1. Goutos I, Dziewulski P, Richardson PM. Pruritus in burns: review article. J Burn Care Res 2009;30:221-8.
2. Goutos I. Burns pruritus-a study of current practices in the UK. Burns 2010;36:42-8.
3. Brooks JP, Malic CC, Judkins KC. Scratching the surface-managing the itch associated with burns: a review of current knowledge. Burns 2008;34:751-60.
4. Goutos I. Re: "Scratching the surface-managing the itch associated with burns: a review of current knowledge" [Burns 34 (2008) 751-760]. Burns 2009;35:754-5; author reply 755-6.
5. Brooks P. Response to letter to the editor Re: "Scratching the surface-managing the itch associated with burns: a review of current knowledge." Burns 2009;35:755-6.
6. Sammer D. Tissue injury and repair. In: Woods E, Rothschild R, eds. Michigan Manual of Plastic surgery. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2004, p. 2-4.
7. Van Loey NE, Bremer M, Faber AW, Middelkoop E, Nieuwenhuis MK. Itching following burns: epidemiology and predictors. Br J Dermatol 2008;158:95-100.
8. Ständer S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003;139:1463-70.
9. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42:45-83.
10. Phillips LG, Robson MC. Pruritus in burns. Comments from Detroit Receiving Hospital, Detroit, Michigan. J Burn Care Rehabil 1988;9:308-9.
11. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE. Specific C-receptors for itch in human skin. J Neurosci 1997;17:8003-8.
12. Ebertz JM, Hirshman CA, Kettelkamp NS, Uno H, Hanifin JM. Substance P-induced histamine release in human cutaneous mast cells. J Invest Dermatol 1987;88:682-5.
13. Drzezga A, Darsow U, Treede RD, et al. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain 2001;92:295-305.
14. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM 2003;96:7-26.
15. Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatol Ther 2005;18:288-91.
16. Goutos I, Eldardiri M, Khan AA, Dziewulski P, Richardson PM. Comparative evaluation of antipruritic protocols in acute burns. The emerging value of gabapentin in the treatment of burns pruritus. J Burn Care Res 2010;31:57-63.
17. Vitale M, Fields-Blache C, Luterman A. Severe itching in the patient with burns. J Burn Care Rehabil 1991;12:330-3.
18. Ahuja RB, Gupta R, Gupta G, Shrivastava P. A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. Burns 2011;37:203-7.
19. Yosipovitch G, Samuel LS. Neuropathic and psychogenic itch. Dermatol Ther 2008;21:32-41.
20. Finnerup NB, Sindrup SH, Jensen TS. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 2007;21:129-36.
21. Ward RS, Saffle JR, Schnebly WA, Hayes-Lundy C, Reddy R. Sensory loss over grafted areas in patients with burns. J Burn Care Rehabil 1989;10:536-8.
22. Malenfant A, Forget R, Amsel R, Papillon J, Frigon JY, Choinière M. Tactile, thermal and pain sensibility in burned patients with and without chronic pain and paresthesia problems. Pain 1998;77:241-51.
23. Bell L, McAdams T, Morgan R, et al. Pruritus in burns: a descriptive study. J Burn Care Rehabil 1988;9:305-8.
24. Paus R, Schmelz M, Bíró T, Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006;116:1174-86.
25. Obreja O, Rukwied R, Steinhoff M, Schmelz M. Neurogenic components of trypsin-and thrombin-induced inflammation in rat skin, in vivo. Exp Dermatol 2006;15:58-65.
26. Scholzen T, Armstrong CA, Bunnett NW, Luger TA, Olerud JE, Ansel JC. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81-96.
27. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat Neurosci 2001;4:72-7.
28. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002;3:655-66.
29. Mochizuki H, Tashiro M, Kano M, Sakurada Y, Itoh M, Yanai K. Imaging of central itch modulation in the human brain using positron emission tomography. Pain 2003;105:339-46.
30. Ständer S, Schmelz M. Chronic itch and pain-similarities and differences. Eur J Pain 2006;10:473-8.
31. Atanassoff PG, Brull SJ, Zhang J, Greenquist K, Silverman DG, Lamotte RH. Enhancement of experimental pruritus and mechanically evoked dysesthesiae with local anesthesia. Somatosens Mot Res 1999;16:291-8.
32. Simone DA, Alreja M, LaMotte RH. Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine. Somatosens Mot Res 1991;8:271-9.
33. Truini A, Cruccu G. Pathophysiological mechanisms of neuropathic pain. Neurol Sci 2006;27 (Suppl 2):S179-82.
34. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron 2006;52:77-92.
35. Li CY, Song YH, Higuera ES, Luo ZD. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 2004;24:8494-9.
36. Finnerup NB, Jensen TS. Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis. Nat Clin Pract Neurol 2006;2:107-15.
37. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996;271:5768-76.
38. Brown JP, Gee NS. Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity. J Biol Chem 1998;273:25458-65.
39. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23-37.
40. Scholz J, Broom DC, Youn DH, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005;25:7317-23.
41. Oaklander AL. Mechanisms of pain and itch caused by herpes zoster (shingles). J Pain 2008;9(1 Suppl 1): S10-8.
42. Dickenson A, Matthews E, Suzuki R. Central nervous system mechanisms of pain in peripheral neuropathy. In: Hansson P, Fields H, Hill R, Marchettini P, editors. Neuropathic pain: pathophysiology and treatment. Seattle, WA: IASP Press; 2001. p. 85-106.
43. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002;25:319-25.
44. Navarro X, Vivó M, Valero-Cabré A. Neural plasticity after peripheral nerve injury and regeneration. Prog Neurobiol 2007;82:163-201.
45. Stella M, Calcagni M, Teich-Alasia S, Ramieri G, Cellino G, Panzica G. Sensory endings in skin grafts and scars after extensive burns. Burns 1994;20:491-5.
46. Henderson J, Terenghi G, McGrouther DA, Ferguson MW. The reinnervation pattern of wounds and scars may explain their sensory symptoms. J Plast Reconstr Aesthet Surg 2006;59:942-50.
47. Ward RS, Tuckett RP, English KB, Johansson O, Saffle JR. Substance P axons and sensory threshold increase in burngraft human skin. J Surg Res 2004;118:154-60.
48. Weidner C, Klede M, Rukwied R, et al. Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J Invest Dermatol 2000;115: 1015-20.
49. Crowe R, Parkhouse N, McGrouther D, Burnstock G. Neuropeptide-containing nerves in painful hypertrophic human scar tissue. Br J Dermatol 1994;130:444-52.
50. Peters EM, Handjiski B, Kuhlmei A, et al. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004;165:259-71.
51. Altun V, Hakvoort TE, van Zuijlen PP, van der Kwast TH, Prens EP. Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars. A 7-month follow-up study of 22 patients. Burns 2001;27:717-22.
52. Straus SE. Shingles. Sorrows, salves, and solutions. JAMA 1993;269:1836-9.
53. Oaklander AL, Cohen SP, Raju SV. Intractable postherpetic itch and cutaneous deafferentation after facial shingles. Pain 2002;96:9-12.
54. Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 2001;92:139-45.
55. Sabel BA. Unrecognised potential of surviving neurones: within systems plasticity, recovery of function, and the hypothesis of minimal residual structure. Neuroscientist 1997; 3:366-70.
56. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
57. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280:1831-6.
58. Cuignet O, Pirson J, Soudon O, Zizi M. Effects of gabapentin on morphine consumption and pain in severely burned patients. Burns 2007;33:81-6.
59. Hill DR, Suman-Chauhan N, Woodruff GN. Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol 1993;244:303-9.
60. Kuzniecky R, Ho S, Pan J, et al. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368-72.
61. Raderer M, Müller C, Scheithauer W. Ondansetron for pruritus due to cholestasis. N Engl J Med 1994; 330:1540.
62. Jones EA. Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy. Lancet 1999;354:397.
63. Gross S, Overbaugh R, Jansen R. Ondansetron for treating itch in healing burns. Internet Journal of Pain, Symptom Control and Palliative Care. 2007;5:1-4.
64. Weisberg J. Transcutaneous electrical nerve stimulation. In: Hecox B, Mehreteab TA, Weisberg J, editors. Physical agents: a comprehensive text for physical therapists. Norwalk, CT: Appleton & Lange; 1994. p. 299-306.
65. Hettrick HH, O'Brien K, Laznick H, et al. Effect of transcutaneous electrical nerve stimulation for the management of burn pruritus: a pilot study. J Burn Care Rehabil 2004;25:236-40.
66. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-9.
67. Kalra A, Urban MO, Sluka KA. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS). J Pharmacol Exp Ther 2001;298:257-63.
68. Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. J Pharmacol Exp Ther 1999;289:840-6.